Stryker

Shoulder Replacement Surgery Risks & Complications

The complication rate following joint replacement surgery is very low. Serious complications, such as joint infection, occur in less than 2% of patients.1. Nevertheless, as with any major surgical procedure, patients who undergo total joint replacement are at risk for certain complications — many of which can be successfully avoided and/or treated. Possible complications include:

Infection

Infection may occur in the wound or within the area around the new joint. It can occur in the hospital, after the patient returns home, or years later. Following surgery, joint replacement patients receive antibiotics to help prevent infection. Joint replacement patients may also need to take antibiotics before undergoing any medical procedures to reduce the chance of infection spreading to the artificial joint.

Treating a Joint Replacement Infection

People who develop infections within the first few months of joint replacement surgery are often treated successfully with intravenous antibiotics and a surgical technique that washes the infected implant. People who develop infections months or years after joint replacement appear to face more challenging treatment. Often these infections require surgical removal of the infected implant, use of a spacer impregnated with antibiotics to stabilize and treat the joint space, and longer-term intravenous antibiotics. Careful blood monitoring helps to determine when the infection is thoroughly cleared. A new joint replacement may be considered at that time.

Blood Clots

Blood clots can result from several factors, including the patient's decreased mobility following surgery, which slows the movement of the blood. There are a number of ways to reduce the possibility of blood clots, including:

Lung Congestion

Pneumonia is always a risk following major surgery. To help keep the lungs clear of congestion, patients are assigned a series of deep breathing exercises.

Reference
1. Hanssen, A.D., et al., “Evaluation and Treatment of Infection at the Site of Total Hip or Knee Arthroplasty,” JBJS, Volume. 80-A, No. 6, June 1998, pp. 910-922.